The changes observed with Exovelle did not fade on treatment day. They were photographed under standardized clinical lighting and measured using computerized ImageJ topography analysis three weeks post-application.
A 2026 systematic review of human clinical trials confirmed significant gains in hydration, elasticity, fine lines, pore refinement, and dermal tolerance.
Topical application of physiological growth factor complexes expanded the grenz zone of newly synthesized collagen fibers directly below the epidermis.
In a double-blind trial of women aged 40 to 65, copper peptide complexes reduced wrinkle volume by 55.8% and depth by 32.8% versus placebo over 8 weeks.
Multi-fractional hyaluronic matrices spiked stratum corneum moisture levels by 134% immediately, maintaining a 55% elevation at 6 weeks.
Subjects received one professional stamping treatment with Exovelle without additional adjuvant therapies. Below are the verified photographic outcomes.
Three weeks after a single 1.5 mL treatment, computerized ImageJ image analysis measured a 21% reduction in wrinkle volume and furrow depth. Visible resolution of micro-vascular redness and chronic erythema was recorded, yielding a calmer, rejuvenated complexion.
Three weeks after one treatment, skin showed marked increases in surface luminescence, dermal turgor, and rosy tone. Computerized ImageJ density evaluation documented an 18% improvement in structural skin firmness, with 100% visible improvement noted by evaluating physicians.
The most unassailable methodology in aesthetic science: treat one hemi-facial plane with Exovelle while leaving the other untouched. Same patient, same genetics, same ambient lighting.
Treated on left side of photograph: The treated side displays a visibly elevated malar fat pad, more sculpted mandibular jawline contour, and smoothed periorbital/under-eye transition.
Treated on right side of photograph: The treated side demonstrates visibly replenished structural fullness in the cheek and sub-orbital trough with a smoother, thicker skin barrier, establishing universal efficacy across male skin physiology.
Four representative patient cohorts monitored under clinical oversight:
| Case | Client Cohort | Clinical Protocol & Design | Follow-up | Documented Outcome |
|---|---|---|---|---|
| 1 | Woman, late seventies | Before & after, single 1.5 mL stamping treatment | 3 weeks | 21% wrinkle reduction (ImageJ analysis); visibly calmer erythema & even complexion |
| 2 | Woman, mid-fifties | Before & after, single 1.5 mL stamping treatment | 3 weeks | 18% firmness improvement (ImageJ analysis); visibly brighter, rosier, and firmer tone |
| 3 | Woman, early fifties | Split-face: treated vs. untreated contralateral side | 3 weeks | Visible lift on treated side; higher cheek contour, refined under-eye texture |
| 4 | Man, mid-fifties | Split-face: treated vs. untreated contralateral side | Post-treatment | Visible fullness on treated side; plumper, smoother male dermal architecture |